	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	23/04/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-02-028882	Time of broadcast: 15:37 15:37

Immediate Report

Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

6k23042025_isa.pdf


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):



Stock Exchange/Market: -1	Date of revision of form structure: 06/08/2024
Address: Einstein 14 , NES-ZIONA 7403618 , ISRAEL Tel: 02-6708072 , Fax: 02-6708070
E-mail address: shachar@enlivexpharm.com Company site: www.enlivex.com

Previous names of reporting entity:

Name of the Signatory: SHLOSBERGER SHACHAR Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: Enlivex thetraputics R
Address: Einstein 14 , nez ziona 7403618 Telephone: 02-6208072 Facsimile: E-mail: shachar@enlivexpharm.com 1
ISRAEL